Retrospective Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Mar 14, 2018; 24(10): 1144-1151
Published online Mar 14, 2018. doi: 10.3748/wjg.v24.i10.1144
Table 1 Baseline patient and tumor characteristics n (%)
CharacteristicValue (n = 51)
Number of patients51
Sex
Male46 (90.2)
Female5 (9.8)
Age, mean ± SD, yr63.6 ± 9.4
Comorbidity
Hypertension21 (41.2)
Diabetes mellitus7 (13.7)
Chronic kidney disease1 (2.0)
Smoker42 (82.4)
Alcohol consumption40 (78.4)
Gross appearance of tumor
Polypoid1 (2.0)
Elevated8 (15.7)
Flat40 (78.4)
Depressed2 (3.9)
Location of tumor
Upper third of esophagus3 (5.9)
Middle third of esophagus20 (39.2)
Lower third of esophagus24 (47.1)
Esophagogastric junction4 (7.8)
Circumferential extension, median (IQR), %40 (30-60)
Pathology of tumor
Dysplasia14 (27.5)
Squamous cell carcinoma37 (72.5)
Invasion depth of tumor
Mucosa38 (74.5)
Submucosa13 (25.5)
Resected area, median (IQR), cm24.5 (2.9-8.2)
Procedure time, median (IQR), min40 (27-69)
Muscle layer exposure
Absent27 (52.9)
Present24 (47.1)
En bloc resection51 (100)
Antibiotics use23 (45.1)
Post procedure BT, mean ± SD, °C36.6 ± 0.5
Post procedure WBC, median (IQR), counts/μL10800 (9340-12600)
Post procedure pain scale score, median (IQR)5 (3-6)
Duration of hospitalization, median (IQR), d4 (3-6)
Post ESD electrocoagulation syndrome
Absent18 (35.3)
Mild24 (47.1)
Severe9 (17.6)